DGAP-News: Oxford Immunotec / Oxford Immunotec receives 2014 Queen's Award for Enterprise 21.04.2014 / 11:00 --------------------------------------------------------------------- OXFORD, United Kingdom and MARLBOROUGH, Mass., 2014-04-21 11:00 CEST (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) today announced that it has received a Queen's Award for Enterprise - the UK's highest accolade in business success. The Queen's Awards are designed to recognise and encourage the achievements by businesses in the UK in the fields of Innovation, International Trade and Sustainable Development. The awards are made annually by Her Majesty The Queen and are only given for the highest levels of excellence demonstrated in each category. Oxford Immunotec received a prestigious Queen's Award for International Trade for Continuous Achievement, based on its substantial overseas revenue growth and commercial success over six years. From 2007 to 2012, Oxford Immunotec grew its overseas earnings by greater than 1300% through expansion into markets worldwide including the United States, Japan and China. The Company's T-SPOT(r).TB test for tuberculosis is now approved for sale in over 50 countries on five continents. The T-SPOT.TB test helps to diagnose tuberculosis infection before it has progressed to full-blown disease, allowing treatment of carriers to prevent further spread of TB infection and disease. Commenting on the Company's achievement, Dr Peter Wrighton-Smith, Oxford Immunotec's Chief Executive Officer, said 'We are delighted and honoured to have the achievements of the Company recognized by Her Majesty. We look forward to continuing to expand the countries we serve and in continuing our strong export-led growth.' Notes to Editors: About Oxford Immunotec Global PLC Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. The proprietary T-SPOT(r) technology platform measures the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. T cells are a central component of the human body's immune system, and are implicated in the control and progression of many medical conditions, including certain types of infectious diseases, cancers and autoimmune diseases. The Company's initial product developed using the T-SPOT technology platform is the T-SPOT.TB test, which is used to test for latent tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, UK and in Marlborough, MA and the Company's shares are traded on The NASDAQ Global Market (Nasdaq:OXFD). Oxford Immunotec was founded in 2002 to commercialise science originating from the University of Oxford. The Company now employs over 150 people in the UK, Continental Europe, US and Japan. Additional information can be found at www.oxfordimmunotec.com. T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd. About The Queen's Award Scheme The Queen's Awards Scheme, originally known as The Queen's Award to Industry, was instituted by Royal Warrant in 1965 and the first awards were made in 1966. HM The Queen makes the Awards on the advice of the Prime Minister who is assisted by an Advisory Committee that includes representatives of Government, industry and commerce, and the trade unions. They are announced annually on 21 April, The Queen's birthday, and are only given for the highest levels of excellence demonstrated in each category. Winners of The Queen's Awards can expect an invitation to attend a special reception at Buckingham Palace. For further information please visit www.queensawards.org.uk. Forward-Looking Statements This release contains forward-looking statements, including statements regarding future success of the company. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. Forward-looking statements are based on current expectations and assumptions and currently available data and are neither predictions nor guarantees of future events or performance. You should not place undue reliance on forward-looking statements, which speak only as of the date of this presentation. We do not undertake to update or revise any forward-looking statements after they are made, whether as a result of new information, future events, or otherwise, except as required by applicable law. CONTACTS: For Media Inquiries: Caroline Crawley Oxford Immunotec Tel: +44 1235 442796 ccrawley@oxfordimmunotec.com For Investor Inquiries: Rick Altieri Chief Financial Officer, Oxford Immunotec Tel: +1 (508) 481-4648 raltieri@oxfordimmunotec.com Mark Klausner Westwicke Partners Tel: +1 (443) 213-0500 oxfordimmunotec@westwicke.com News Source: NASDAQ OMX End of Corporate News --------------------------------------------------------------------- 21.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Oxford Immunotec United Kingdom ISIN: GB00BGFBB958 End of News DGAP News-Service --------------------------------------------------------------------- 263900 21.04.2014
DGAP-News: Oxford Immunotec receives 2014 Queen's Award for
Top 10 Most Recent News Articles
CureGene's Evategrel Aims for Breakthrough in Stroke Care
Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...
Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise
Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...
Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study
Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...
Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps
In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...
Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone
Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...
Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High
They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...
Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment
Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...
Continue Reading
Ericsson Buybacks: Strategic Moves or Market Maneuver?
Breaking Down Ericsson's Strategic Share Buybacks When a company like Ericsson starts pulling stocks off the shelves like they're on sale, it's time to take notice. Between November 2nd and 6th, Ericsson, that telecom giant we all know, went on a little shopping spree, snapping up 500,000 of its own Class B shares. Why should we care? Well, it's a part of their hefty SEK...
Continue Reading
Inside Kristallnacht: An XR Journey for a New World
Bridging the Past with Powerful Tech: A Journey to Kristallnacht Let's cut to the chase: if there's a time in history that we all need to sear into our collective consciousness, it's Kristallnacht. Forget the mere notion of reading it from a textbook; now you can dive headfirst into the harrowing events of November 9, 1938, thanks to the cutting-edge initiative inside...
Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue ReadingTop 5 Most Recently Viewed Articles
Critical Metals Corp Unveils Impressive Rare Earth Findings
Exciting Discoveries from the Tanbreez Project Critical Metals Corp, a prominent player in mining development, recently announced the remarkable results of its 2024 drilling program at the Tanbreez Rare Earth Project. These findings emphasize the continuous mineralization of rare earth elements, underlining the project's promising potential. The results highlight key...
Continue Reading
Silver Star Properties REIT Addresses Shareholder Concerns
Silver Star Properties REIT Responds to Former CEO's Claims In a significant move to maintain transparency, Silver Star Properties REIT, Inc. has addressed recent statements from its former CEO, Al Hartman. The company, focused on repositioning itself within the self-storage asset class, is dedicated to ensuring its shareholders have access to accurate information amidst...
Continue Reading
Atico Mining Restructures Credit Facility with Trafigura
Atico Mining Partners with Trafigura on Credit Restructuring VANCOUVER, British Columbia – Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) has made significant strides towards financial stability by entering into a term sheet with Trafigura PTE. LTD. This agreement represents an essential amendment and extension of Atico's existing...
Continue Reading
Walmart Embraces AI Revolution in Retail Operations
AI Transformation at Walmart In today's rapidly evolving world, no job can claim to be untouchable, including those involved in tasks like retrieving shopping carts from parking lots. This stark reality was articulated by Walmart's CEO Doug McMillon during a recent event. He emphasized that the introduction of artificial intelligence (AI) will impact every role at...
Continue Reading
Family RV Association Welcomes Doug Uhlenbrock as New Leader
Family RV Association Announces Executive Director Appointment CINCINNATI – Doug Uhlenbrock, who has dedicated 24 years of his career to the Family RV Association, has been appointed as the new executive director of the organization. This decision comes after the Executive Board unanimously supported his transition into this significant leadership position. Experience...
Continue Reading